阿富汗麻疹暴发风险:免疫系统中断后的省级免疫缺口与流行潜力
基于2022-23年阿富汗MICS household调查数据,计算省级MCV1覆盖率并构建传播潜力指数Rcov,发现所有34省Rcov均大于1,常规单剂接种在数学上不足以达到群体免疫阈值,需持续两剂常规接种和高覆盖补充免疫活动。
要点
- 全国MCV1覆盖率51.2%,省级范围8.6%-88.7%,所有34省Rcov均大于1。
- 单剂常规接种理论覆盖需求为100.36%,两剂系列(VE₂=0.97)需求为96.22%。
核心结论
- 在中心假设下,仅常规MCV1接种在数学上不足以达到群体免疫阈值。
- 高两剂系列覆盖率理论上可达阈值,但操作要求高,需持续两剂常规接种、高覆盖SIA和免疫系统能力恢复。
研究设计与样本
- 利用2022-23年阿富汗MICS数据,获取12-23月龄儿童省级MCV1覆盖率(未加权n=6177;加权n=6383)。
- 计算覆盖调整传播潜力指数Rcov=R₀×(1-MCV1×VE₁),取R₀=15、VE₁=0.93。
- 运行确定性SEIR情景和随机tau-leaping模拟,潜伏期均值8天、感染期4天。
主要发现
- 省级MCV1覆盖率范围8.6%-88.7%,所有34省Rcov>1(范围2.63-13.80;U5加权聚合7.95)。
- 单剂理论覆盖需求100.36%,两剂系列(VE₂=0.97)需求96.22%。
- 九个示例省份单次输入建立概率范围65.9%-93.9%;WHO第14周监测与Rcov呈正序地理一致性(Kendall τb=0.331;Spearman ρ=0.430;均p=0.011)。
关键数值与推荐
- Rcov计算公式:R₀=15,VE₁=0.93。
- 两剂疫苗效果VE₂=0.97。
- 单剂理论覆盖需求100.36%,两剂系列需求96.22%。
临床怎么用
- 省级Rcov均大于1提示各地均存在麻疹传播潜力,需维持两剂常规接种并开展高覆盖SIA。
- 优先 targeting 可显著降低SIA所需儿童数,应结合省级覆盖率缺口规划补充免疫活动。
- 监测数据与Rcov的地理一致性支持将覆盖率衍生指标用于风险分层。
局限性
- 监测比较为回顾性,支持地理一致性而非外部模型验证。
- 模型依赖中心假设(R₀=15、VE₁=0.93、VE₂=0.97)及调查不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the 2021 political transition, Afghanistan's routine immunisation system experienced disruption. The 2022-23 Afghanistan Multiple Indicator Cluster Survey (MICS) estimated national first-dose measles-containing vaccine (MCV1) coverage at 51.2% (95% CI 49.1-53.2). Provincial heterogeneity in coverage-derived measles transmission potential has not been quantified using these household survey data. METHODS: Provincial MCV1 coverage among children aged 12-23 months was obtained from the 2022-23 MICS (unweighted n = 6177; weighted n = 6383). We calculated a coverage-adjusted transmission-potential index, Rcov = R₀ × (1 - MCV1 × VE₁), using R₀ = 15 and one-dose vaccine effectiveness (VE₁) = 0.93. Deterministic SEIR scenarios and complementary stochastic tau-leaping simulations were run using an 8-day mean latent period and 4-day infectious-compartment duration. Survey uncertainty, upper-bound routine-MCV1 protection gaps, and preferential- and random-targeting SIA requirements were quantified. RESULTS: Provincial MCV1 coverage ranged from 8.6% to 88.7%, and all 34 provinces had Rcov > 1 (range 2.63-13.80; U5-weighted aggregate 7.95). The theoretical one-dose coverage requirement was 100.36%, whereas the requirement for a complete two-dose series using empirical VE₂ = 0.97 was 96.22%. The standardized 3.5-year upper-bound accumulation of children remaining unprotected by routine MCV1 was 3.02 million (conditional 95% interval 2.92-3.12 million). The province-summed SIA requirement was 4.06 million children (49.8% of U5) under idealized preferential targeting and 7.53 million (92.4%) under random targeting. Single-importation establishment probability ranged from 65.9% to 93.9% across nine illustrative provinces. WHO week-14 surveillance showed positive ordinal geographic concordance with Rcov (Kendall τb = 0.331; Spearman ρ = 0.430; both p = 0.011). CONCLUSIONS: Routine MCV1 alone is mathematically insufficient to reach the population-immunity threshold under the central assumptions. High complete two-dose-series coverage remains theoretically capable of reaching the threshold but is operationally demanding. Sustained routine two-dose delivery, high-reach SIAs, and restoration of immunisation-system capacity are likely to be required. The surveillance comparison is retrospective and supports geographic concordance rather than external model validation.
引用
- Ranjan R, Anwari P, Colson A, et al. Measles outbreak risk in Afghanistan: provincial immunity gaps and epidemic potential following immunisation system disruption. Vaccine. 2026. PMID: 42641255. doi:10.1016/j.vaccine.2026.129078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。